HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm's Attorneys Now, Securities Fraud Case Filed

SAN FRANCISCO, June 28, 2021 /PRNewswire/ -- Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now. A securities class action has been filed and certain investors may have valuable claims. Class Period: Sept. 18, 2020 - June 17,...

from PR Newswire: https://ift.tt/3w4hIFu